[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Melatonin-EMEA Market Status and Trend Report 2013-2023

February 2018 | 143 pages | ID: MA230131167EN
MIReports Co., Limited

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Melatonin-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Melatonin industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole EMEA and Regional Market Size of Melatonin 2013-2017, and development forecast 2018-2023
Main market players of Melatonin in EMEA, with company and product introduction, position in the Melatonin market
Market status and development trend of Melatonin by types and applications
Cost and profit status of Melatonin, and marketing status
Market growth drivers and challenges

The report segments the EMEA Melatonin market as:

EMEA Melatonin Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

Europe
Middle East
Africa

EMEA Melatonin Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

Pharmaceutical Grade
Food Grade

EMEA Melatonin Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Dietary Supplements
Medical
Other

EMEA Melatonin Market: Players Segment Analysis (Company and Product introduction, Melatonin Sales Volume, Revenue, Price and Gross Margin):

Natrol
Pharmavite
Nature's Bounty
Jameison
Rexall Sundown
GNC
Xiu Zheng
Church & Dwight
By-Health
Pfizer
Solgar
Biotics Research
Now Food

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

CHAPTER 1 OVERVIEW OF MELATONIN

1.1 Definition of Melatonin in This Report
1.2 Commercial Types of Melatonin
  1.2.1 Pharmaceutical Grade
  1.2.2 Food Grade
1.3 Downstream Application of Melatonin
  1.3.1 Dietary Supplements
  1.3.2 Medical
  1.3.3 Other
1.4 Development History of Melatonin
1.5 Market Status and Trend of Melatonin 2013-2023
  1.5.1 EMEA Melatonin Market Status and Trend 2013-2023
  1.5.2 Regional Melatonin Market Status and Trend 2013-2023

CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Melatonin in EMEA 2013-2017
2.2 Consumption Market of Melatonin in EMEA by Regions
  2.2.1 Consumption Volume of Melatonin in EMEA by Regions
  2.2.2 Revenue of Melatonin in EMEA by Regions
2.3 Market Analysis of Melatonin in EMEA by Regions
  2.3.1 Market Analysis of Melatonin in Europe 2013-2017
  2.3.2 Market Analysis of Melatonin in Middle East 2013-2017
  2.3.3 Market Analysis of Melatonin in Africa 2013-2017
2.4 Market Development Forecast of Melatonin in EMEA 2018-2023
  2.4.1 Market Development Forecast of Melatonin in EMEA 2018-2023
  2.4.2 Market Development Forecast of Melatonin by Regions 2018-2023

CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES

3.1 Whole EMEA Market Status by Types
  3.1.1 Consumption Volume of Melatonin in EMEA by Types
  3.1.2 Revenue of Melatonin in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
  3.2.1 Market Status by Types in Europe
  3.2.2 Market Status by Types in Middle East
  3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Melatonin in EMEA by Types

CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Melatonin in EMEA by Downstream Industry
4.2 Demand Volume of Melatonin by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Melatonin by Downstream Industry in Europe
  4.2.2 Demand Volume of Melatonin by Downstream Industry in Middle East
  4.2.3 Demand Volume of Melatonin by Downstream Industry in Africa
4.3 Market Forecast of Melatonin in EMEA by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF MELATONIN

5.1 EMEA Economy Situation and Trend Overview
5.2 Melatonin Downstream Industry Situation and Trend Overview

CHAPTER 6 MELATONIN MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA

6.1 Sales Volume of Melatonin in EMEA by Major Players
6.2 Revenue of Melatonin in EMEA by Major Players
6.3 Basic Information of Melatonin by Major Players
  6.3.1 Headquarters Location and Established Time of Melatonin Major Players
  6.3.2 Employees and Revenue Level of Melatonin Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 MELATONIN MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Natrol
  7.1.1 Company profile
  7.1.2 Representative Melatonin Product
  7.1.3 Melatonin Sales, Revenue, Price and Gross Margin of Natrol
7.2 Pharmavite
  7.2.1 Company profile
  7.2.2 Representative Melatonin Product
  7.2.3 Melatonin Sales, Revenue, Price and Gross Margin of Pharmavite
7.3 Nature's Bounty
  7.3.1 Company profile
  7.3.2 Representative Melatonin Product
  7.3.3 Melatonin Sales, Revenue, Price and Gross Margin of Nature's Bounty
7.4 Jameison
  7.4.1 Company profile
  7.4.2 Representative Melatonin Product
  7.4.3 Melatonin Sales, Revenue, Price and Gross Margin of Jameison
7.5 Rexall Sundown
  7.5.1 Company profile
  7.5.2 Representative Melatonin Product
  7.5.3 Melatonin Sales, Revenue, Price and Gross Margin of Rexall Sundown
7.6 GNC
  7.6.1 Company profile
  7.6.2 Representative Melatonin Product
  7.6.3 Melatonin Sales, Revenue, Price and Gross Margin of GNC
7.7 Xiu Zheng
  7.7.1 Company profile
  7.7.2 Representative Melatonin Product
  7.7.3 Melatonin Sales, Revenue, Price and Gross Margin of Xiu Zheng
7.8 Church & Dwight
  7.8.1 Company profile
  7.8.2 Representative Melatonin Product
  7.8.3 Melatonin Sales, Revenue, Price and Gross Margin of Church & Dwight
7.9 By-Health
  7.9.1 Company profile
  7.9.2 Representative Melatonin Product
  7.9.3 Melatonin Sales, Revenue, Price and Gross Margin of By-Health
7.10 Pfizer
  7.10.1 Company profile
  7.10.2 Representative Melatonin Product
  7.10.3 Melatonin Sales, Revenue, Price and Gross Margin of Pfizer
7.11 Solgar
  7.11.1 Company profile
  7.11.2 Representative Melatonin Product
  7.11.3 Melatonin Sales, Revenue, Price and Gross Margin of Solgar
7.12 Biotics Research
  7.12.1 Company profile
  7.12.2 Representative Melatonin Product
  7.12.3 Melatonin Sales, Revenue, Price and Gross Margin of Biotics Research
7.13 Now Food
  7.13.1 Company profile
  7.13.2 Representative Melatonin Product
  7.13.3 Melatonin Sales, Revenue, Price and Gross Margin of Now Food

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MELATONIN

8.1 Industry Chain of Melatonin
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF MELATONIN

9.1 Cost Structure Analysis of Melatonin
9.2 Raw Materials Cost Analysis of Melatonin
9.3 Labor Cost Analysis of Melatonin
9.4 Manufacturing Expenses Analysis of Melatonin

CHAPTER 10 MARKETING STATUS ANALYSIS OF MELATONIN

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications